ZA200804110B - An oxidation process for the preparation of N-[3-amino-1-(cyclobutylmethyl)-2,3- dioxopropyl]-3-{N-[(tert-buty-lamino)carbonyl]-3-methyl-L-valyl}-6,6-dimethyl-3-azabicy-clo[3.1.0]hexane-2-carboxamide and related compounds - Google Patents

An oxidation process for the preparation of N-[3-amino-1-(cyclobutylmethyl)-2,3- dioxopropyl]-3-{N-[(tert-buty-lamino)carbonyl]-3-methyl-L-valyl}-6,6-dimethyl-3-azabicy-clo[3.1.0]hexane-2-carboxamide and related compounds

Info

Publication number
ZA200804110B
ZA200804110B ZA200804110A ZA200804110A ZA200804110B ZA 200804110 B ZA200804110 B ZA 200804110B ZA 200804110 A ZA200804110 A ZA 200804110A ZA 200804110 A ZA200804110 A ZA 200804110A ZA 200804110 B ZA200804110 B ZA 200804110B
Authority
ZA
South Africa
Prior art keywords
azabicy
dioxopropyl
lamino
valyl
buty
Prior art date
Application number
ZA200804110A
Other languages
English (en)
Inventor
George G Wu
Rashatasakhon Paitoon
Poirier Marc
Xie Ji
Chen Frank Xing
Victoria M Sprague
Original Assignee
Schering Corp
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Schering Corp filed Critical Schering Corp
Publication of ZA200804110B publication Critical patent/ZA200804110B/xx

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D209/00—Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom
    • C07D209/02—Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom condensed with one carbocyclic ring
    • C07D209/52—Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom condensed with one carbocyclic ring condensed with a ring other than six-membered
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A61P31/14—Antivirals for RNA viruses
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K5/00—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof
    • C07K5/02—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing at least one abnormal peptide link
    • C07K5/0202—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing at least one abnormal peptide link containing the structure -NH-X-X-C(=0)-, X being an optionally substituted carbon atom or a heteroatom, e.g. beta-amino acids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Molecular Biology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Veterinary Medicine (AREA)
  • Biophysics (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Biochemistry (AREA)
  • Virology (AREA)
  • Genetics & Genomics (AREA)
  • Crystallography & Structural Chemistry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Communicable Diseases (AREA)
  • Oncology (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Indole Compounds (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Low-Molecular Organic Synthesis Reactions Using Catalysts (AREA)
  • Plural Heterocyclic Compounds (AREA)
ZA200804110A 2005-11-14 2008-05-13 An oxidation process for the preparation of N-[3-amino-1-(cyclobutylmethyl)-2,3- dioxopropyl]-3-{N-[(tert-buty-lamino)carbonyl]-3-methyl-L-valyl}-6,6-dimethyl-3-azabicy-clo[3.1.0]hexane-2-carboxamide and related compounds ZA200804110B (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US73654205P 2005-11-14 2005-11-14

Publications (1)

Publication Number Publication Date
ZA200804110B true ZA200804110B (en) 2009-03-25

Family

ID=37963789

Family Applications (1)

Application Number Title Priority Date Filing Date
ZA200804110A ZA200804110B (en) 2005-11-14 2008-05-13 An oxidation process for the preparation of N-[3-amino-1-(cyclobutylmethyl)-2,3- dioxopropyl]-3-{N-[(tert-buty-lamino)carbonyl]-3-methyl-L-valyl}-6,6-dimethyl-3-azabicy-clo[3.1.0]hexane-2-carboxamide and related compounds

Country Status (8)

Country Link
US (1) US7528263B2 (xx)
EP (1) EP1966233B1 (xx)
JP (2) JP5215863B2 (xx)
CN (1) CN101356187A (xx)
AR (1) AR056805A1 (xx)
CA (1) CA2628738A1 (xx)
WO (1) WO2008010831A1 (xx)
ZA (1) ZA200804110B (xx)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP5247466B2 (ja) * 2005-12-22 2013-07-24 メルク・シャープ・アンド・ドーム・コーポレーション ６，６−ジメチル−３−アザビシクロ−［３．１．０］−ヘキサン化合物およびその鏡像異性体塩を調製するプロセス
US8188137B2 (en) 2008-08-15 2012-05-29 Avila Therapeutics, Inc. HCV protease inhibitors and uses thereof
MX2013012771A (es) * 2011-05-04 2013-11-21 Merck Sharp & Dohme Proceso para la preparacion de inhibidores del virus de la hepatitis c.
WO2014061034A1 (en) * 2012-10-18 2014-04-24 Msn Laboratories Limited Process for preparation of boceprevir and intermediates thereof
CA3200437A1 (en) * 2020-12-01 2022-06-09 Arun K. Ghosh Compounds for the treatment of sars

Family Cites Families (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5238602A (en) 1984-07-16 1993-08-24 Hoffmann La Roche Inc. Liquid crystals
US7244721B2 (en) * 2000-07-21 2007-07-17 Schering Corporation Peptides as NS3-serine protease inhibitors of hepatitis C virus
DK1385870T3 (da) * 2000-07-21 2010-07-05 Schering Corp Peptider som inhibitorer af NS3-serinprotease fra hepatitis C-virus
US6587902B1 (en) 2001-12-27 2003-07-01 Inventec Corporation I/O port assembly of notebook computer connectable to monitor or TV as needed
US20050059684A1 (en) * 2002-10-16 2005-03-17 Ben-Zion Dolitzky Method for reducing residual alcohols in crystalline valacyclovir hydrochloride
CN101823965B (zh) * 2003-06-17 2012-12-19 默沙东公司 制备(1r,2s,5s)-6,6-二甲基-3-氮杂双环[3,1,0]己烷-2-羧酸酯或其盐的方法和中间体
AR044694A1 (es) * 2003-06-17 2005-09-21 Schering Corp Proceso y compuestos intermedios para la preparacion de (1r, 2s,5s) - 3 azabiciclo [3,1,0] hexano-2- carboxamida, n- [3- amino-1- (ciclobutilmetil) - 2, 3 - dioxopropil] -3- [ (2s) - 2 - [[ [ 1,1- dimetiletil] amino] carbonilamino] -3,3-dimetil -1- oxobutil]-6,6 dimetilo
WO2004113272A1 (en) * 2003-06-17 2004-12-29 Schering Corporation Process and intermediates for the preparation of 3-(amino)-3-cyclobutylmethyl-2-hydroxy-propionamide or salts thereof
EP1730165A1 (en) 2004-02-27 2006-12-13 Schering Corporation Inhibitors of hepatitis c virus ns3 protease
WO2005107745A1 (en) * 2004-05-06 2005-11-17 Schering Corporation An inhibitor of hepatitis c

Also Published As

Publication number Publication date
CN101356187A (zh) 2009-01-28
AR056805A1 (es) 2007-10-24
US20070149459A1 (en) 2007-06-28
WO2008010831A1 (en) 2008-01-24
JP5215863B2 (ja) 2013-06-19
EP1966233A1 (en) 2008-09-10
CA2628738A1 (en) 2008-01-24
US7528263B2 (en) 2009-05-05
JP2009515894A (ja) 2009-04-16
JP2013032370A (ja) 2013-02-14
EP1966233B1 (en) 2014-08-13

Similar Documents

Publication Publication Date Title
IL189008A (en) History of 1-Naphthalenyl-3-azabicyclo [0.1.3] hexane
EP2481721A3 (en) Product mixtures comprising sevoflurane, sevochlorane and sevochlorane hydrolysis products.
TWI347201B (en) Pharmaceutical products,uses thereof and methods for preparing the same
HK1084387A1 (en) Process and intermediates for the preparation of (1r, 2s, 5s)-3-azabicycloÄ3, 1, 0Ühexane-2-carboxamide, n-Ä3-amino-1-(cyclobutylmethyl)-2, 3-dioxopropylÜ-3-Ä(2s)-2-ÄÄÄ1, 1-dimethylethylÜaminoÜcarbonyla minoÜ-3, 3-dimethyl-1-oxobutylÜ-6, 6-dimethyl
WO2006127898A3 (en) (s)-n-methylnaltrexone, process for its synthesis and its pharmaceutical use
MX284594B (es) Catalizador de oxidacion y procedimiento para su preparacion y procedimiento para oxidacion mediante el uso del mismo.
EP1651195A4 (en) PHARMACEUTICAL PROCESSES, DOSIERSCHEMATA AND DOSAGE FORMS FOR THE TREATMENT OF ALZHEIMER DISEASE
EP1676512A3 (en) Skin treatment articles and methods
ZA200804110B (en) An oxidation process for the preparation of N-[3-amino-1-(cyclobutylmethyl)-2,3- dioxopropyl]-3-{N-[(tert-buty-lamino)carbonyl]-3-methyl-L-valyl}-6,6-dimethyl-3-azabicy-clo[3.1.0]hexane-2-carboxamide and related compounds
WO2006060753A3 (en) Diagnosis and treatment of alzheimer's disease
EP1327448A4 (en) AGENTS MAINTAINING HOMEOSTASE
EP1731139A4 (en) PHARMACEUTICAL PREPARATION OF THE S / O TYPE AND MANUFACTURING METHOD THEREFOR
EP1731041A4 (en) PROCESS FOR PREPARING SOY PROTEIN AND METHOD FOR PRODUCING A MEAT PROCESSING PRODUCT WITH SOY PROTEIN
WO2006103672A3 (en) Spherically shaped substances
PL398391A1 (pl) Koniugat hydroksyalkiloskrobi i polipeptydu, sposób wytwarzania tego koniugatu, jego zastosowanie oraz kompozycja farmaceutyczna zawierająca koniugat hydroksyalkiloskrobi i polipeptydu
IL165012A0 (en) (S)-4-Amino-5-chloro-2-methoxy-N-Ä1-(-tetrahydrofurylcarbonyl)-4-piperidinylmethylÜ-4-piperidinylÜbenzamide, process for the preparation thereof, pharmaceutical composition containing the same, and intermediate therefor
WO2007144169A3 (en) Entacapone-derivatives
AU2003259112A8 (en) Enzymatic process for the preparation of foods, feedstuffs and ingredients therefor
ZA200904330B (en) Process for preparing (1R, 2S,5S)-N-[(1S)-3-amino-1-(cyclobutylmethyl)-2-3-dioxopropyl]-3-3[(2S)-2[[[1,1-dimethylethyl)amino]-carbonyl]amino]-3,3-dimethyl-1-oxobutyl]-6,6-dimethyl-3-azabicyclo[3.1.0]hexane-2-carboxamide
MXPA02012249A (es) Peptidos, composiciones y metodos para el tratamiento de burkholderia cepacia.
EP1719523A4 (en) MICROPARTICULAR PROTEIN CARBIDE RETARD PREPARATION FOR INJECTION AND METHOD FOR THE PRODUCTION THEREOF
IL190464A0 (en) Cyclic n-[1,3,4]-thiadiazol-2-yl-benzene sulfonamides, processes for their preparation and their use as pharmaceuticals
MX2009006477A (es) Purificacion de bisulfito de una alfa-ceto amida.
MX2009006720A (es) Preparacion de clorhidrato de 3-amino-3-(ciclobutilmetil)-2(hidrox i)-propionamida.
SI1979053T1 (sl) Proizvod za zdravljenje kožnih in sluzničnih membran in ustrezni postopek za pripravo